All over 50s and all clinically vulnerable individuals have now been offered a first Covid vaccine dose. The government has managed to meet its target of 15th April, and it will now begin targeting people in their late 40s.
According to government officials, the UK is still on track to offer a first dose to all adults by the end of July. It means that everyone will have at least some level of protection this summer. However, not everyone has been taking up the offer of a vaccine, although some believe the UK will develop some level of herd immunity by later this year.
Over 32 million now vaccinated
Figures show that more than 32 million people across the UK have now been vaccinated with their first dose. On Saturday, close to half a million doses were administered, a new daily record for the UK. In addition, 7.6 people in the UK have now received first and second doses.
With lockdown restrictions being gradually eased, ministers are keen for everyone who receives an invitation to get themselves vaccinated. NHS England has stated that 95% of the groups offered their vaccinations so far have had their first doses, so the take-up rate appears to be pretty high.
Ministers are urging those who are over 50 or in a vulnerable group to take action if they have not yet received their invitation for a first dose. Those not yet been invited to make an appointment to receive a vaccine should enquire with their GP.
Chris Hopson, chief executive of NHS Providers, said, "As we return to pub gardens and sports activities and make our way back to non-essential shops, we must continue to do all that we can to prevent the spread of infection and ensure this lockdown will be the last."
Another vaccine now being rolled out
Since the start of this year, the UK has been administering jabs from Pfizer and AstraZeneca. A third vaccine - the Moderna jab - is now being rolled out in the UK.
Initially, the Moderna vaccine will be offered at 21 sites across the UK. It will enable health officials to offer another alternative to younger people in place of the AstraZeneca jab, which has been under scrutiny due to possible links to blood clots.
Image Credit: GroupEditor